<document id="DDI-DrugBank.d386">
    <sentence id="DDI-DrugBank.d386.s3" text="Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.">
        <entity charOffset="69-93" id="DDI-DrugBank.d386.s3.e0" text="tricyclic antidepressants" type="group" />
        <entity charOffset="96-99" id="DDI-DrugBank.d386.s3.e1" text="TCAs" type="group" />
        <pair ddi="false" e1="DDI-DrugBank.d386.s3.e0" e2="DDI-DrugBank.d386.s3.e1" id="DDI-DrugBank.d386.s3.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d386.s12" text="Nevertheless, caution is indicated in the co-administration of T.A. with any of the SSRIs and also in switching from one class to the other.">
        <entity charOffset="63-66" id="DDI-DrugBank.d386.s12.e0" text="T.A." type="group" />
        <entity charOffset="84-88" id="DDI-DrugBank.d386.s12.e1" text="SSRIs" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d386.s12.e0" e2="DDI-DrugBank.d386.s12.e1" id="DDI-DrugBank.d386.s12.p0" type="advise" />
    </sentence>
    <sentence id="DDI-DrugBank.d386.s14" text="Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.">
        <entity charOffset="19-43" id="DDI-DrugBank.d386.s14.e0" text="tricyclic antidepressants" type="group" />
        <entity charOffset="156-179" id="DDI-DrugBank.d386.s14.e1" text="tricyclic antidepressant" type="group" />
        <pair ddi="false" e1="DDI-DrugBank.d386.s14.e0" e2="DDI-DrugBank.d386.s14.e1" id="DDI-DrugBank.d386.s14.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d386.s16" text="It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.">
        <entity charOffset="27-29" id="DDI-DrugBank.d386.s16.e0" text="TCA" type="group" />
        <entity charOffset="56-58" id="DDI-DrugBank.d386.s16.e1" text="TCA" type="group" />
        <pair ddi="false" e1="DDI-DrugBank.d386.s16.e0" e2="DDI-DrugBank.d386.s16.e1" id="DDI-DrugBank.d386.s16.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d386.s18" text="Close supervision and careful adjustment of dosage are required when this drug is given concomitantly with anticholinergic or sympathomimetic drugs.">
        <entity charOffset="107-121" id="DDI-DrugBank.d386.s18.e0" text="anticholinergic" type="group" />
        <entity charOffset="126-146" id="DDI-DrugBank.d386.s18.e1" text="sympathomimetic drugs" type="group" />
        <pair ddi="false" e1="DDI-DrugBank.d386.s18.e0" e2="DDI-DrugBank.d386.s18.e1" id="DDI-DrugBank.d386.s18.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d386.s24" text="Both the sedative and anticholinergic effects of the major tranquilizers are also additive to those of desipramine.">
        <entity charOffset="53-71" id="DDI-DrugBank.d386.s24.e0" text="major tranquilizers" type="group" />
        <entity charOffset="103-113" id="DDI-DrugBank.d386.s24.e1" text="desipramine" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d386.s24.e0" e2="DDI-DrugBank.d386.s24.e1" id="DDI-DrugBank.d386.s24.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d386.s28" text="There have been greater than two-fold increases of previously stable plasma levels of tricyclic antidepressants when fluoxetine has been administered in combination with these agents.">
        <entity charOffset="86-110" id="DDI-DrugBank.d386.s28.e0" text="tricyclic antidepressants" type="group" />
        <entity charOffset="117-126" id="DDI-DrugBank.d386.s28.e1" text="fluoxetine" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d386.s28.e0" e2="DDI-DrugBank.d386.s28.e1" id="DDI-DrugBank.d386.s28.p0" type="mechanism" />
    </sentence>
</document>